Skip to content

Sanlian Xingshen Yizhi Acupuncture for mild and moderate Alzheimer's disease: a clinical trial

Sanlian Xingshen Yizhi Acupuncture for mild and moderate Alzheimer's disease: a clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048788
Enrollment
Unknown
Registered
2021-07-16
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Interventions

Sponsors

Beijing Royal Integrative Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Meet the necessary conditions for "probable AD" formulated by NINCDR-ADRDA and the diagnostic criteria for senile dementia in the "Guidelines for Clinical Research on New Chinese Medicines"; 2. Memory loss >= 6 months, and confirmed by others; 3. Aged 45 to 90 years; 4. Meet the mild and moderate criteria of the CDR rating scale (1 point = mild dementia, 2 points = moderate dementia); 5. MMSE score <=24 points (middle school and above), <=20 points (primary school), <=17 points (illiterate); 6. Hanchinski score<=4 points; 7. The patient is willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Dementia caused by other reasons; 2. Patients with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, mental illness; 3. Acupuncture fainting or patients who cannot tolerate acupuncture pain; 4. Participated in similar investigators within 3 months.

Design outcomes

Primary

MeasureTime frame
Mini Mental Status Examination;

Countries

China

Contacts

Public ContactJi Bo

Beijing University of Chinese Medicine

jibo678@263.net+86 13911806678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026